Arbeidet vi finansierer (kun på engelsk)

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

GAP5 - TIGER Trial in relapsing Germ Cell Tumour

Movember Funding to Date

Global funding AUD equivalent 1,291,964.25

What we seek to achieve

This project supports the European Organisation for Research and Treatments in Cancer (EORTC) to provide sponsorship for the TIGER trial in Europe. The TIGER trial is a very large multinational clinical trial investigating which of the two current and commonly used treatments is more effective in preventing death in men who show a relapse of testicular cancer.

Country
Belgium
Implemented by
The Movember Foundation
Project start date
August 2015
Project Status
In progress

About the project

Testicular Cancer is a highly treatable disease. In approximately 95% of men, an effective cure can be obtained using first line treatments. However in a small number of men, the disease returns and these men often have a poorer outcome in terms of overall survival and side effects of more toxic treatments. The current standard therapy varies around the world and the TIGER trial aspires to determine which of the current two treatments is more effective. Given that relapse after chemotherapy is quite rare in testicular cancer, a large number of recruiting centres are required to efficiently accrue patients into the study. 420 patients will be recruited worldwide, with 192 of these scheduled to be recruited in European countries and 60 in Australian and New Zealand sites.

The trial strives to guide future clinical practice for the men who are not effectively treated in the first case by chemotherapy. This will guide and shape the treatment of these men to be more appropriate for their circumstance and also potentially reduce unnecessary side effects.

This project has been governed by the Movember Testicular Cancer Research Advisory Committee - a global team of highly regarded experts in the field that have guided and shaped the project.

(Local investment EUR 1,291,964)

Prostate Cancer Research Alliance

The Program will fund research that leverages Australia's existing strengths in prostate cancer biomedical research to deliver outcomes that can be translated into clinical practice within the next 5 to 7 years.

Find out more
Australia
AUD 12,150,000
USA - Mass market, multi-platform public media documentary series & campaign

This project uses a mass market, multi dimensional campaigns to shift populations understanding, attitudes and intentions and ultimately improve health outcomes on a large scale. Focusing on Youth Mental Health we will be working in partnership with PBS to deliver a documentary series supported with educational, digital and in person elements delivered across the USA.

Find out more
United States
USD 2,400,000
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
South Africa
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Spain
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Ireland
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Switzerland
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Sweden
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United States
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United Kingdom
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Canada
Global Funding AUD equivalent 18,905,25
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Australia
Global Funding AUD equivalent 18,905,25
Movember – Distinguished Gentleman’s Ride Clinician Scientist Award - 2017

Clinician Scientist Awards aim to support outstanding, clinically qualified professionals who have gained a PhD in health research, to combine their clinical career with a research career and establish themselves as independent researchers in the field of prostate cancer.

Find out more
Australia
-
TrueNTH Global Registry

Established in 2017 and operating across 17 countries, the TrueNTH Global Registry is an international project that aims to improve the physical and mental health of men with prostate cancer. Clinicians and hospitals contributing data to TrueNTH Global Registry receive regular, risk-adjusted reports on their patients’ health outcomes as compared to other clinicians and hospitals globally. This will support improvement in clinical practice and patient outcomes over time.

Find out more
Australia
Global funding AUD equivalent 20,336,828
Canadian Men's Health & Wellbeing Innovation Challenge

To support the implementation of outside the box proof of concept ideas that disrupt long held assumptions/myths about men and their health which will encourage doing things differently and ultimately lead to improved health outcomes.

Find out more
Canada
CAD 1,923,149
Prostate Cancer Outcomes - Registry Australia and New Zealand

The Prostate Cancer Outcomes Registry of Australia and New Zealand (PCOR-ANZ) is a clinical quality registry collecting data on the diagnosis, clinical care and outcomes for men living with prostate cancer across Australia and New Zealand.

Find out more
Australia
Global funding AUD equivalent 22,397,860
TrueNTH Testicular Cancer

TrueNTH Testicular Cancer is a website, optimised for mobile devices, that aims to bring resources to men who are facing a diagnosis and early treatment for testicular cancer. We have created a resource that delivers information to men to help them navigate the early stages of treatment along with the functionality to connect with a survivor who has lived through the same experience to facilitate peer support and a capacity to seek advice from experts in the field relating to the Testicular Cancer Journey. 

Find out more
Australia
AUD 1,180,594
>
Page 1 of 31